Participant Diversity in United States Randomized Controlled Trials of Antibacterials for Staphylococcus aureus Infections, 2000-2021.
Jiye KwonWilliam PelletiersJessica Galloway PeñaDavid Van DuinLeila LedbetterKeri BaumFelicia RuffinJane M KniselyErica BizzellVance G FowlerHenry F ChambersMelinda M PettigrewPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Standardized reporting methods for race and ethnicity and efforts to increase recruitment of marginalized groups would help ensure equity, rigor, and generalizability in RCTs of antibacterial agents and reduce health inequities.